drugset / Trial / NCT00882063
Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine safety of P276-00 in patients with advanced multiple myeloma and whether P276-00 is effective in the treatment of advanced cases of multiple myeloma.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-11
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | P276-00 | Small molecule | 50 mg/m2 | Intravenous |